Met Life Investment Management, LLC Oncocyte Corp Transaction History

Met Life Investment Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$3.53 - $5.89 $102,228 - $170,574	-28,960 Closed	0 $0
Q2 2021 May 17, 2024	BUY	$3.77 - $6.0 $102,623 - $163,326	27,221 Added 1565.32%	28,960 $166,000
Q2 2021 Jun 21, 2023	BUY	$3.77 - $6.0 $109,179 - $173,760	28,960 New	28,960 $166,000
Q2 2021 Mar 22, 2023	BUY	$3.77 - $6.0 $102,623 - $163,326	27,221 Added 1565.32%	28,960 $166,000
Q2 2021 Aug 16, 2021	BUY	$3.77 - $6.0 $102,623 - $163,326	27,221 Added 1565.32%	28,960 $166,000
Q1 2021 May 17, 2024	BUY	$2.39 - $6.5 $4,156 - $11,303	1,739 New	1,739 $9,000
Q1 2021 Jun 26, 2023	BUY	$2.39 - $6.5 $4,156 - $11,303	1,739 New	1,739 $9.03 Million
Q1 2021 Mar 22, 2023	BUY	$2.39 - $6.5 $4,156 - $11,303	1,739 New	1,739 $9,000
Q1 2021 May 14, 2021	BUY	$2.39 - $6.5 $4,156 - $11,303	1,739 New	1,739 $9,000

399K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $246M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Met Life Investment Management, LLC with notifications on news.